Article Text

other Versions

PDF
Ultrasonographic Evaluation of Splenic Enlargement in Athletes with Acute Infectious Mononucleosis.
  1. Robert G. Hosey (rhosey{at}email.uky.edu)
  1. University of Kentucky, United States
    1. Vesna Kriss (vkris0{at}uky.edu)
    1. University of Kentucky, United States
      1. Timothy L. Uhl
      1. University of Kentucky, United States
        1. John DiFiori
        1. University of California, Los Angeles, United States
          1. Suzanne Hecht
          1. University of Minnesota, United States
            1. Wen Y Dennis
            1. University of Missouri - Columbia, United States

              Abstract

              Objective: To quantitatively assess the degree and rate of splenic enlargement and the time required for regression of splenic enlargement in collegiate athletes diagnosed with acute infectious mononucleosis (IM).

              Design: Prospective Cohort study.

              Setting: Academic Medical Center(s) outpatient sports medicine clinic.

              Study Participants: Volunteer Division I University athletes.

              Interventions: A limited abdominal ultrasound was performed on each participant by a licensed and experienced ultrasonographer. Splenic measurements were taken to assess maximum splenic length. Athletes that were subsequently diagnosed with infectious mononucleosis (clinical illness and a positive Monospot) underwent serial splenic ultrasounds and physical exams (weekly) until resolution of clinical symptoms and splenic enlargement (as determined by ultrasound measurements).

              Main Outcome Measures: Percent enlargement of spleen size (length) from baseline. Time (in days) from onset of clinical illness to maximum splenic length. Time (in days) required for resolution of splenic enlargement.

              Results: Twenty subjects were diagnosed with acute IM during over a five-year time period. Maximum splenic length increased a mean of 33.6% ± 19.9% from baseline values. Peak splenic enlargement was reached a mean of 12.3 ± 5.1 days from onset of clinical illness. A linear model demonstrated that spleen size decreases approximately 1% per day after reaching peak splenic enlargement.

              Conclusions: The majority of athletes with IM experience a moderate degree of splenomegaly. Peak splenic enlargement occurred within two weeks from the time of symptom onset in most cases, but may extend to 3.5 weeks. The rate of splenic enlargement appears to be predictable for an individual who develops IM. Ultrasonographic data further show that splenomegaly associated with acute IM infection resolves within 4-6 weeks of symptom onset in the majority of cases.

              Statistics from Altmetric.com

              Request permissions

              If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.